This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: The Innovations of Anne-Marie Dechert Schmitt
Introduction
Anne-Marie Dechert Schmitt is a prominent inventor based in Westerly, Rhode Island. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 2 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Among her latest inventions are the Azalactam compounds as HPK1 inhibitors. This invention relates to compounds of general Formula I, which have potential applications in treating various diseases. The focus on HPK1 inhibitors highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Anne-Marie is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her role at Pfizer allows her to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Throughout her career, Anne-Marie has worked alongside talented colleagues, including Rebecca Anne Gallego and Sajiv Krishnan Nair. These collaborations have played a crucial role in her innovative endeavors and have helped to foster a dynamic research environment.
Conclusion
Anne-Marie Dechert Schmitt's contributions to the field of pharmaceuticals through her patents and collaborations exemplify her dedication to innovation. Her work continues to impact the industry positively, paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile